Clinical trial
Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease
NCT05151458 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 29, 2021
- Completion date
- November 30, 2022
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.